General Information of Drug (ID: DML2VUC)

Drug Name
PMID28350212-Compound-25 Drug Info
Cross-matching ID
TTD Drug ID
DML2VUC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID28350212-Compound-18 DMH8GC6 Alzheimer disease 8A20 Patented [1]
PMID28350212-Compound-7 DMUBSFV Herpes simplex virus infection 1F00 Patented [1]
PMID28350212-Compound-24 DMPJH6L N. A. N. A. Patented [1]
PMID28350212-Compound-19 DMI4US6 Alzheimer disease 8A20 Patented [1]
PMID28350212-Compound-35 DMSKE2O N. A. N. A. Patented [1]
PMID28350212-Compound-23 DM3MVW1 N. A. N. A. Patented [1]
PMID28350212-Compound-22 DMKXZYC N. A. N. A. Patented [1]
PMID28350212-Compound-13 DMPWYL8 N. A. N. A. Patented [1]
PMID28350212-Compound-1 DMSEIL0 N. A. N. A. Patented [1]
PMID28350212-Compound-36 DM7ULWD N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Gamma-secretase subunit APH-1A/1B (APH-1) TTZS04O APH1A_HUMAN-APH1B_HUMAN Inhibitor [1]

References

1 Gamma secretase inhibitors: a patent review (2013 - 2015).Expert Opin Ther Pat. 2017 Jul;27(7):851-866.